Literature DB >> 32485332

SARS-CoV-2 Molecular and Phylogenetic analysis in COVID-19 patients: A preliminary report from Iran.

Alireza Tabibzadeh1, Farhad Zamani2, Azadeh Laali3, Maryam Esghaei1, Fahimeh Safarnezhad Tameshkel2, Hossein Keyvani4, Mahin Jamshidi Makiani3, Mahshid Panahi5, Nima Motamed6, Dhayaneethie Perumal7, Mahmoodreza Khoonsari2, Hossein Ajdarkosh2, Masuodreza Sohrabi2, Behrooz Ghanbari2, Shokoufeh Savaj8, Alireza Mosavi-Jarrahi9, Mohammad Hadi Karbalaie Niya10.   

Abstract

BACKGROUND: The aim of the current study was to investigate and track the SARS-CoV-2 in Iranian Coronavirus Disease 2019 (COVID-19) patients using molecular and phylogenetic methods.
METHODS: We enrolled seven confirmed cases of COVID-19 patients for the phylogenetic assessment of the SARS-CoV-2 in Iran. The nsp-2, nsp-12, and S genes were amplified using one-step RT-PCR and sequenced using Sanger sequencing method. Popular bioinformatics software were used for sequences alignment and analysis as well as phylogenetic construction.
RESULTS: The mean age of the patients in the present study was 60.42 ± 9.94 years and 57.1% (4/7) were male. The results indicated high similarity between Iranian and Chinese strains. We could not find any particular polymorphisms in the assessed regions of the three genes. Phylogenetic trees by neighbor-joining and maximum likelihood method of nsp-2, nsp-12, and S genes showed that there are not any differences between Iranian isolates and those of other countries.
CONCLUSION: As a preliminary phylogenetic study in Iranian SARS-CoV-2 isolates, we found that these isolates are closely related to the Chinese and reference sequences. Also, no sensible differences were observed between Iranian isolates and those of other countries. Further investigations are recommended using more comprehensive methods and larger sample sizes.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  COVID-19; Pandemic; Phylogeny; Viral infection

Mesh:

Substances:

Year:  2020        PMID: 32485332     DOI: 10.1016/j.meegid.2020.104387

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  7 in total

Review 1.  Genome interaction of the virus and the host genes and non-coding RNAs in SARS-CoV-2 infection.

Authors:  Juliana M Serpeloni; Quirino Alves Lima Neto; Léia Carolina Lucio; Anelisa Ramão; Jaqueline Carvalho de Oliveira; Daniela Fiori Gradia; Danielle Malheiros; Adriano Ferrasa; Rafael Marchi; David L A Figueiredo; Wilson A Silva; Enilze M S F Ribeiro; Ilce M S Cólus; Luciane R Cavalli
Journal:  Immunobiology       Date:  2021-08-17       Impact factor: 3.152

2.  Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing.

Authors:  Jayanta Kumar Das; Giuseppe Tradigo; Pierangelo Veltri; Pietro H Guzzi; Swarup Roy
Journal:  Brief Bioinform       Date:  2021-03-22       Impact factor: 11.622

Review 3.  Essential interpretations of bioinformatics in COVID-19 pandemic.

Authors:  Manisha Ray; Mukund Namdev Sable; Saurav Sarkar; Vinaykumar Hallur
Journal:  Meta Gene       Date:  2020-12-17

4.  Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins.

Authors:  Sanghoo Lee; Mi-Kyeong Lee; Hyeongkyun Na; Jinwoo Ahn; Gayeon Hong; Youngkee Lee; Jimyeong Park; Yejin Kim; Yun-Tae Kim; Chang-Ki Kim; Hwan-Sub Lim; Kyoung-Ryul Lee
Journal:  Gene Rep       Date:  2021-03-23

Review 5.  A contemporary review on the important role of in silico approaches for managing different aspects of COVID-19 crisis.

Authors:  Mohammad Moradi; Reza Golmohammadi; Ali Najafi; Mehrdad Moosazadeh Moghaddam; Mahdi Fasihi-Ramandi; Reza Mirnejad
Journal:  Inform Med Unlocked       Date:  2022-01-21

6.  Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China.

Authors:  Yaping Wang; Ruchong Chen; Fengyu Hu; Yun Lan; Zhaowei Yang; Chen Zhan; Jingrong Shi; Xizi Deng; Mei Jiang; Shuxin Zhong; Baolin Liao; Kai Deng; Jingyan Tang; Liliangzi Guo; Mengling Jiang; Qinghong Fan; Meiyu Li; Jinxin Liu; Yaling Shi; Xilong Deng; Xincai Xiao; Min Kang; Yan Li; Weijie Guan; Yimin Li; Shiyue Li; Feng Li; Nanshan Zhong; Xiaoping Tang
Journal:  EClinicalMedicine       Date:  2021-09-12

7.  COVID-19: The question of genetic diversity and therapeutic intervention approaches.

Authors:  David Livingstone Alves Figueiredo; João Paulo Bianchi Ximenez; Fábio Rodrigues Ferreira Seiva; Carolina Panis; Rafael Dos Santos Bezerra; Adriano Ferrasa; Alessandra Lourenço Cecchini; Alexandra Ivo de Medeiros; Ana Marisa Fusco Almeida; Anelisa Ramão; Angelica Beate Winter Boldt; Carla Fredrichsen Moya; Chung Man Chin; Daniel de Paula; Daniel Rech; Daniela Fiori Gradia; Danielle Malheiros; Danielle Venturini; Eliandro Reis Tavares; Emerson Carraro; Enilze Maria de Souza Fonseca Ribeiro; Evani Marques Pereira; Felipe Francisco Tuon; Franciele Aní Caovilla Follador; Glaura Scantamburlo Alves Fernandes; Hélito Volpato; Ilce Mara de Syllos Cólus; Jaqueline Carvalho de Oliveira; Jean Henrique da Silva Rodrigues; Jean Leandro Dos Santos; Jeane Eliete Laguila Visentainer; Juliana Cristina Brandi; Juliana Mara Serpeloni; Juliana Sartori Bonini; Karen Brajão de Oliveira; Karine Fiorentin; Léia Carolina Lucio; Ligia Carla Faccin-Galhardi; Lirane Elize Defante Ferreto; Lucy Megumi Yamauchi Lioni; Marcia Edilaine Lopes Consolaro; Marcelo Ricardo Vicari; Marcos Abdo Arbex; Marcos Pileggi; Maria Angelica Ehara Watanabe; Maria Antônia Ramos Costa; Maria José S Mendes Giannini; Marla Karine Amarante; Najeh Maissar Khalil; Quirino Alves de Lima Neto; Roberto H Herai; Roberta Losi Guembarovski; Rogério N Shinsato; Rubiana Mara Mainardes; Silvana Giuliatti; Sueli Fumie Yamada-Ogatta; Viviane Knuppel de Quadros Gerber; Wander Rogério Pavanelli; Weber Claudio da Silva; Maria Luiza Petzl-Erler; Valeria Valente; Christiane Pienna Soares; Luciane Regina Cavalli; Wilson Araujo Silva
Journal:  Genet Mol Biol       Date:  2022-04-08       Impact factor: 2.087

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.